Synergistic activity of linifanib and irinotecan increases the survival of mice bearing orthotopically implanted human anaplastic thyroid cancer

Anaplastic thyroid cancer (ATC) is the most aggressive form of thyroid cancer, and novel combined therapies are urgently needed to prolong patient survival. No data are currently available on the preclinical activity of the combination of linifanib, a CSF-1R inhibitor, and irinotecan in ATC. The aim...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cancer Res
Autors principals: Banchi, Marta, Orlandi, Paola, Gentile, Daniela, Alì, Greta, Fini, Elisabetta, Fontanini, Gabriella, Francia, Giulio, Bocci, Guido
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7407355/
https://ncbi.nlm.nih.gov/pubmed/32775005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars